• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

J&J Launches Patient Outcome and Cost-Reducing Approach in EMEA


Pharmaceutical Executive

Johnsons & Johnson Medical Devices (JJMD) launched CareAdvantage, a new approach to assist in driving value-based healthcare in hospitals across Europe, Middle East, and Africa (EMEA). The approach is holistic and driven by data.

The healthcare market is changing, with pressure to meet the “triple aim” of improving outcomes, increase patient satisfaction, and reduce costs. The focus is shifting from volume to value; therefore, there is a growing need for new delivery models, resulting in rapid transformation for hospital systems, clinicians, and their patients. 

CareAdvantage focuses on four areas-improving the patient experience, driving supply chain efficiencies, building clinical partnerships, and providing commercial support.

Related Videos